Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 64,400 | 33,200 | 79,200 | 62,800 | 40,700 |
| Depreciation Amortization | 48,500 | 24,300 | 93,600 | 69,400 | 45,700 |
| Income taxes - deferred | 15,500 | 7,300 | 15,700 | -5,000 | -4,000 |
| Accounts receivable | -31,200 | -28,900 | 13,600 | 1,900 | -3,200 |
| Accounts payable and accrued liabilities | 35,300 | 44,000 | -13,400 | 1,500 | 400 |
| Other Working Capital | -69,300 | -42,000 | -67,400 | -49,000 | -61,900 |
| Other Operating Activity | -4,500 | -15,200 | 11,100 | 8,000 | 18,200 |
| Operating Cash Flow | $58,700 | $22,700 | $132,400 | $89,600 | $35,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35,700 | -16,900 | -93,800 | -60,900 | -37,600 |
| Net Acquisitions | N/A | N/A | -101,600 | -103,400 | N/A |
| Other Investing Activity | 9,800 | 9,800 | 100 | 100 | 100 |
| Investing Cash Flow | $-25,900 | $-7,100 | $-195,300 | $-164,200 | $-37,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -200 | -100 | -300 | N/A | N/A |
| Debt Issued | N/A | N/A | 198,900 | 198,900 | 198,900 |
| Debt Repayment | N/A | N/A | -100,000 | -100,000 | -100,000 |
| Common Stock Issued | 11,500 | 2,900 | 14,500 | 11,800 | 8,300 |
| Common Stock Repurchased | -13,200 | -13,200 | -27,700 | -19,800 | -12,300 |
| Dividend Paid | -7,800 | -3,900 | N/A | N/A | N/A |
| Other Financing Activity | 2,700 | 2,700 | 0 | 0 | 0 |
| Financing Cash Flow | $-7,000 | $-11,600 | $85,400 | $90,900 | $94,900 |
| Exchange Rate Effect | -6,900 | -3,500 | 18,600 | 8,100 | 5,900 |
| Beginning Cash Position | 251,100 | 251,100 | 210,000 | 210,000 | 210,000 |
| End Cash Position | 270,000 | 251,600 | 251,100 | 234,400 | 309,200 |
| Net Cash Flow | $18,900 | $500 | $41,100 | $24,400 | $99,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,700 | 22,700 | 132,400 | 89,600 | 35,900 |
| Capital Expenditure | -35,700 | -16,900 | -93,800 | -60,900 | -37,600 |
| Free Cash Flow | 23,000 | 5,800 | 38,600 | 28,700 | -1,700 |